Nerve-Repair injection shows promise for wrist pain
NCT ID NCT06328166
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether an injection of ES135, a lab-made version of a natural growth factor, could help people with carpal tunnel syndrome. Twenty-four adults with confirmed CTS received either ES135 or a placebo injection guided by ultrasound. Researchers tracked changes in symptoms, hand function, and pain over six months to see if the treatment is safe and effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ES135 (recombinant human fibroblast growth factor 1)
What this could lead to
If it works, this could offer a new injection-based treatment to ease pain and improve hand function in people with carpal tunnel syndrome.
What could go wrong
This is a very small, early-stage trial with only 24 participants. The results may not apply to everyone, and the treatment may not prove more effective than a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARPAL TUNNEL SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
No. 325, Sec. 2, Chenggong Rd., Neihu Dist.
Taipei, 114, Taiwan